Allergic airway disease is known to cause significant morbidity due to impaired mucociliary clearance, however the mechanism that leads to the mucus dysfunction is not entirely understood. Interleukin 13 (IL-13), a key mediator of Type 2 (T2) inflammation, profoundly alters the ion transport properties of airway epithelium. However, these electrophysiological changes cannot explain the thick, tenacious airway mucus that characterizes the clinical phenotype. Here we report that IL-13 dramatically increases the airway surface liquid (ASL) viscosity in cultured primary human bronchial epithelial cells and thereby inhibits mucus clearance. These detrimental rheological changes require ATP12A, a nongastric H + /K + -ATPase that secretes protons into the ASL. ATP12A knockdown or inhibition prevented the IL-13 dependent increase in ASL viscosity but did not alter the ASL pH. We propose that ATP12A promotes airway mucus dysfunction in individuals with T2 inflammatory airway diseases and that ATP12A may be a novel therapeutic target to improve mucus clearance.
Results
IL-13 reduces the ASL meniscus volume, inhibits ciliary function, and impairs mucus transport. Primary human bronchial epithelial (HBE) cells were cultured on an air-liquid interface and allowed to differentiate. To simulate the effects of T2 inflammation, the differentiated cell cultures were treated with IL-13 (10 ng/mL) for 3-5 days in the basolateral media. As shown in Fig. 1a , a marked change was noted in the appearance of the mucosal surface of the cells following exposure to IL-13. We have previously shown that the airway surface liquid (ASL) forms a meniscus at the interface between the epithelial cell surface and the cell culture transwell filter wall and that this meniscus contains the vast majority of the apical volume. To measure the volume of the ASL contained within the meniscus on HBE cells cultured with IL-13, the cell culture plates were scanned using an optical scanner and the magnitude of the meniscus was measured by analyzing the pattern of light refraction through the fluid 34 . The volume of the ASL meniscus is markedly decreased when HBE cells are exposed to IL-13 as shown in the representative culture images (Fig. 1a , orange outline) and meniscus tracings ( Fig. 1b ). As shown in Fig. 1c , the ASL meniscus volume was dramatically decreased when the HBE cells were exposed to IL-13 and this was independent of tissue donor disease state ( Supplementary Fig. S1 ). These results indicate that the mucosal airway surface was profoundly altered in the presence of IL-13.
We next assessed whether the IL-13 dependent decreases in ASL volume were sufficient to impair mucociliary transport. To assess ciliary function, we measured the fraction of functional ciliated airway (FFCA), an estimate of the percentage of motile cilia that are able to participate in MCC 35 . A series of sequential images of the HBE cell culture's apical surface were obtained. As motile cilia will lead to variations in light intensity, the changes of pixel intensity over time directly correlates with regions of increased ciliary motion. As shown in Fig. 2a ,b, IL-13 substantially reduced the FFCA compared to control, suggesting that ciliary function is impaired by IL-13. When the apical surface was rinsed and hydrated with several rinses of Ringer's solution, the FFCA was restored suggesting these changes were not due to direct effects on the cilia. Representative FFCA images are shown in Fig. 2a and the aggregate data of FFCA relative to rinsed control shown in Fig. 2b . As an additional assessment of ciliary function, the ciliary beat frequency (CBF) was measured in HBE following apical rinsing 36 . Although the overall values remained slightly decreased, CBF in IL-13 treated HBE cells approached that of control ( Fig. 2c ), a finding that is consistent with previous studies of the effect of IL-13 on CBF 26, 37 .
Next, to examine whether IL-13 treatment impairs MCC, we measured the rate of rotational mucociliary transport (MCT) in HBE cell cultures. Fluorescent microspheres were added to the apical mucus and the cells were examined 24 h later to allow for the apical fluid bolus to be reabsorbed. An image of the microspheres was then captured with a 5 s exposure. The distance traveled by the microspheres was measured allowing for the calculation of the rotational velocity as previously described 5 . Representative images of the microsphere movement are shown in Fig. 2d . IL-13 exposure dramatically reduced the MCT rate in HBE cell cultures as shown in Fig. 2e . Collectively, these data support the hypothesis that IL-13 impairs ciliary function and mucus transport 26, 37 . Active ion transport is required for IL-13 dependent ASL meniscus absorption. The current paradigm of ASL volume homeostasis is that Na + absorption is balanced by Cl − secretion 2 . Published work in primary HBE and animal models of asthma suggest that T2 inflammatory stimuli may promote ASL secretion [20] [21] [22] . However, this is inconsistent with both the rheology of asthmatic mucus and the profound decrease in ASL meniscus volume observed in our HBE cell culture model following IL-13 exposure. To reconcile this potential contradiction, we performed a series of experiments to determine whether active ion transport is required for the development of IL-13 mediated reduction in ASL meniscus volume. First, short-circuit experiments were performed to confirm that our cell culture model is consistent with previously published reports of ion transport alterations in IL-13 treated HBE cell cultures. As shown in the representative short-circuit current tracings in Fig. 3a , amiloride was applied to measure the epithelial sodium channel (ENaC) mediated Na + absorption (I Na ). Forskolin was then added to stimulate Cl − secretion prior to measuring the bumetanide sensitive Cl − secretion (I Cl ). IL-13 treatment substantially reduced electrogenic Na + absorption and increased electrogenic Cl − secretion, as shown in Fig. 3b and in prior reports [20] [21] [22] .
Next, we determined whether active ion transport mediates the IL-13 induced changes in the appearance of the HBE mucosal surface. Overall ion transport was blocked through the inhibition of the basolateral Na + / K + -ATPase with ouabain. A small bolus of Ringer's solution was then added apically and the ASL meniscus volume was measured over time. As shown in Fig. 3c , absorption of the apical bolus was blocked by basolateral ouabain in HBE cultures with and without IL-13. We then compared absorption rates following the addition of a small bolus of fluid where the physiologic salts had been replaced with non-absorbable isosmotic mannitol. IL-13 is increased by IL-13, but is unchanged when ion transport is inhibited by 100 µM basolateral ouabain or through the addition of 10 μL of apical isosmotic mannitol solution. Data shown are mean absorption rate ± SEM (µL/cm 2 /hr), n = 3 tissue donors with 6 experimental replicates per donor, **p = 0.0151, ***p = 0.0453, and ****p = 0.0130 all via unpaired Student's t-test. Control conditions are represented in black, IL-13 treated conditions are represented in red.
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The reduction in the ASL meniscus volume in IL-13 treated cells is due to altered mucus rheology. In contrast to the finding that the ASL meniscus volume is depleted by IL-13, prior studies suggest that IL-13 may increase the ASL height of airway epithelia 18, 19 . To reconcile this, we measured the ASL height in HBE cell cultures through the addition of a small bolus of non-absorbable fluorescent dextran applied to the apical surface. The ASL height was measured with confocal microscopy the following day to allow for volume reabsorption (representative images shown in Fig. 4a ) 38 . The change in ASL height in IL-13 treated cells was highly variable across HBE that were cultured from different tissue donors such that the aggregate data surprisingly did not lead to a change in ASL height as shown in Fig. 4b .
The marked reduction in ASL meniscus volume without a concomitant reduction in ASL height is seemingly contradictory. However, the ASL is a complex fluid comprised of water, mucins, and other macromolecules that determine the ASL's physical properties 39, 40 . Interactions between these surface active components, the apical epithelial membrane, and the transwell filter wall determine how the ASL is partitioned between the thin film and the meniscus. We have previously reported that the overall ASL volume is predominantly partitioned in the meniscus and that changes in the ASL height do not substantially contribute to the measured volume 34 . For example, an increase in ASL height from 10 µm to 20 µm in a transwell filter with a 0.33 cm 2 surface area (6.5 mm diameter) increases the ASL volume by only 0.33 µL (Volume = height * π * r 2 ). Thus, the measured ASL meniscus volume is influenced both by ion transport processes that determine the apical hydration status and by the rheology of the ASL which can alter the partitioning of the ASL across the cell culture surface.
Therefore, we explored the possibility that the reduced volume contained in the meniscus could be explained by an IL-13 dependent alteration in the ASL rheology. The viscosity of a fluid can be inferred by measuring the rate of diffusion of a tracer through the fluid. The ASL was labeled with non-absorbable florescent dextran and the rate of fluorescence recovery after photobleaching (FRAP) was measured the following day 41 . Following photobleaching, the rate of signal recovery was markedly reduced in cells exposed to IL-13, suggesting that the ASL is significantly more viscous in IL-13 treated cells. Representative signal tracings are shown in Fig. 4c and the aggregate data is shown in Fig. 4d . While HCO 3 − and CO 2 were not present in the basolateral bath or ambient conditions for the reported data, IL-13 also increased the ASL viscosity when the FRAP was measured in cells placed in a HCO 3 − and CO 2 containing environment (data not shown). This increase in ASL viscosity is consistent with previous reports of the mucus rheology in IL-13 treated airway epithelia and in subjects with asthma 23-25 . ATP12A expression is increased by IL-13. Evidence suggests that ASL viscosity is influenced by its pH 11 .
Therefore, we hypothesized that the increased ASL viscosity observed in IL-13 treated cells may be caused by a reduction in the ASL pH. To measure ASL pH, the ratiometric pH sensitive dye, BCECF, was applied to the apical surface and the fluorescent ratio of 490/440 nm was measured 42 . When the cells were maintained in physiologic conditions (at 37 °C in the presence of HCO 3 − and 5% CO 2 ), the ASL was slightly more alkaline in IL-13 treated cells as shown in Fig. 5a . This is not unexpected due to the previously demonstrated increase in expression and activity of pendrin (SLC26A4), an apical, electroneutral, Cl − /HCO 3 − exchanging protein 18, 19 . We then measured the rate of ASL acidification following the apical addition of alkaline fluids (pH 7.5) with and without bicarbonate . Data shown represents mean rate of ASL pH change ± SEM (ΔpH/min) from 9 culture filters from 3 tissue donors, **p < 0.0001 by unpaired Student's t-test. (c) IL-13 driven proton secretion is potassium dependent. The apical surface was rinsed with 0 mM K + or 20 mM K + prior to pH measurements. Data represents mean rate of ASL pH change ± SEM (ΔpH/min) from 12 replicates from 3 tissue donors, **p < 0.0001 by unpaired Student's t-test and **p = 0.0002 by paired Student's t-test. (d) IL-13 mediated increases in apical proton secretion is sensitive to apical ouabain. Rate of ASL pH change was measured in HBE cells cultures ± IL-13 after the addition of a 10 µL bolus of an alkaline solution (pH 7.5). The filters were then rinsed thoroughly and a second 10 µL alkaline bolus with 50 µM apical ouabain was added and the rate of ASL pH change was measured. Data shown represents mean rate of ASL pH change ± SEM (ΔpH/min) from 6 culture filters from 2 tissue donors, ****p = 0.0005 and *p < 0.0001 by unpaired Student's t-test and *****p = 0.0175 by paired Student's t-test. was replaced with a similar concentration of HEPES buffer (20 mM). As shown in Fig. 5b , the rate of acidification was elevated in IL-13 treated cells in the absence of HCO 3 − . This indicates that IL-13 treated cells have an increased capacity to secrete protons in addition to the previously described increases in HCO 3 − secretion. ATP12A is an electroneutral H + /K + -ATPase that absorbs extracellular potassium ions (K + ) in exchange for hydrogen ion (H + ) secretion. ATP12A is believed to be the primary mechanism for proton secretion in to the ASL, and it has been previously demonstrated that ASL acidification is dependent on ASL K + concentration 30, 31 . To assess if the increased rate of acidification mediated by IL-13 was due to ATP12A, we assessed for the rate of ASL acidification in low potassium and high potassium conditions (0 mM K + vs 20 mM K + ) and, as shown in Fig. 5c , the accelerated rate of proton secretion caused by IL-13 is [K + ] dependent. In agreement with the hypothesis that IL-13 dependent ASL acidification is mediated by ATP12A, apical ouabain inhibited proton secretion as shown in Fig. 5d . Apical ouabain decreased the ASL viscosity in IL-13 treated cells as shown in Supplementary  Fig. S2 . These results suggest that ATP12A mediated proton secretion contributes to the development of increased ASL viscosity in IL-13 treated HBE cell culture.
To confirm that the IL-13 driven effect on proton secretion and ASL viscosity are due to changes in ATP12A expression, HBE cells were exposed to IL-13 and immunoblotting and rtPCR was performed. ATP12A protein and mRNA expression increased 3-4 fold after being cultured with IL-13. A sample immunoblot is shown in Fig. 6a and the aggregate data across multiple tissue donors is shown in Fig. 6b (protein) and Fig. 6c (mRNA) . These results indicate that IL-13 exposure increases ATP12A expression, in agreement with recent microarray data demonstrating that ATP12A expression is increased in HBE cell cultures treated with IL-4, another T2 inflammatory cytokine 43 . Il-13 dependent ATP12A expression increases mucus viscosity. To determine whether ATP12A is required for IL-13's effect of mucus rheology, a series of experiments were performed to knockdown ATP12A expression. Initially, we identified dicer substrate siRNA that inhibited ATP12A expression ( Supplementary  Fig. S3a ) and this was protective against IL-13 dependent reduction in ASL meniscus volume ( Supplementary  Fig. S3b ). However, as shown in Supplementary Fig. S3c , the knockdown was transient and did not persist to allow for the cells to fully differentiate, limiting our ability to evaluate additional physiological changes at the apical surface. Therefore, we generated lentivirus that expressed ATP12A shRNA to permanently reduce ATP12A expression. As shown in Fig. 6d-f , the transduction of a lentivirus expressing shRNA directed towards ATP12A persistently reduced its expression in primary HBE cells and prevented the IL-13 mediated reduction in ASL meniscus volume (Fig. 7a) .
To directly determine whether ATP12A contributes to IL-13 mediated increases in ASL viscosity, FRAP was performed on the ATP12A shRNA knockdown (KD) HBE cells. As shown in a representative FRAP tracing ( Fig. 7b ) and aggregate data from multiple tissue donors (Fig. 7c ), ATP12A KD HBE cells were largely protected from IL-13 induced increases in mucus viscosity. The small increase in ASL viscosity that developed following IL-13 exposure in the ATP12A KD HBE cells is directly proportional to the degree of residual ATP12A expression as shown in Fig. 7d . These results indicate that ATP12A contributes to the development of highly viscous mucus in IL-13 treated HBE and suggest that ATP12A promotes mucus dysfunction during airway T2 inflammation.
As ATP12A has previously been shown to be the primary acidifier of the ASL, we hypothesized that ATP12A KD would increase the ASL pH. Surprisingly, ATP12A KD had no effect on the steady-state ASL pH both in the presence and absence of IL-13 as shown in Fig. 7e . We next measured the effect of ATP12A KD on proton secretion in HCO 3 − free conditions ± IL-13. In contrast to the finding that ATP12A KD did not affect steady state ASL pH, ATP12A KD cultures had reduced IL-13 dependent proton secretion proportional to the degree of residual ATP12A expression ( Fig. 7f) . These results suggest that while ATP12A functions as a proton pump, the overall contribution to steady state ASL pH is modest.
Discussion
We have demonstrated that the Type 2 (T2) inflammatory cytokine, IL-13, impairs mucociliary clearance (MCC) by altering the mucus rheology in primary HBE cell culture. IL-13 decreased the airway surface liquid (ASL) meniscus volume with associated impairments in ciliary function and reduction in mucus transport rates. The IL-13 mediated increase in ASL viscosity occurred despite electrophysiological properties that favor ASL secretion and predict a reduction in viscosity 17, [20] [21] [22] . The primary novel finding of this work is that the increased ASL viscosity seen with IL-13 exposure was mediated through the apical non-gastric proton pump, ATP12A. In support of ATP12A's pivotal role in IL-13 mediated mucus dysfunction, ATP12A inhibition and knockdown prevented the development of mucus hyperviscosity in IL-13 treated primary cultures of HBE. Therefore, ATP12A appears to be a key mediator of mucus dysfunction in T2 airway disease.
Several lines of evidence support the hypothesis that airway T2 inflammation increases ATP12A expression and thereby promotes mucus dysfunction. IL-13 exposure increased ATP12A expression and function as evidenced by the higher rate of potassium-dependent, ouabain-sensitive proton secretion in IL-13 treated HBE cultures (Figs 5b-d and 6a-c). Recent work by Gorrieri et al. demonstrated that IL-4, another T2 inflammatory cytokine, led to increases in ATP12A expression and dramatically reduced the ASL K + concentration, potentially due increased K + absorption through ATP12A 43 . ATP12A expression was highly correlated with ASL viscosity in our experiments. Additionally, ATP12A overexpression modestly increased the ASL viscosity in CFTR −/− mice 33 . Thus, ATP12A appears to be a novel regulator of ASL viscosity and likely contributes to the airway dysfunction that occurs during T2 inflammation.
ATP12A mediates electroneutral hydrogen ion (H + ) secretion exchange for potassium ions (K + ) and is believed to function as a primary acidifier of the ASL 30, 31 . However, the ASL pH increased following IL-13 exposure regardless of whether ATP12A was expressed (Figs 5a and 7d) . These modest effects of ATP12A on the steady state ASL pH were unanticipated, and there are several potential explanations for the lack of correlation between ATP12A expression and ASL pH. First, recent data suggest that bicarbonate readily passes through paracellular pathways in human airway epithelium 44 . The modest ASL acidification rates that we and others have observed in HCO 3 − containing conditions (Fig. 5b ) supports the notion that paracellular HCO 3 − permeability is high in airway epithelium 33 . Thus, paracellular HCO 3 − transport is likely to buffer the increased proton secretion though ATP12A in IL-13 treated cells. Additionally, the modest effect of ATP12A on ASL pH following IL-13 exposure can be further explained by the concomitant increase in pendrin (SLC26A4) expression during T2 inflammation 18, 19 . As pendrin encodes an apical Cl − /HCO 3 − exchanging protein, the ATP12A mediated proton secretion may be masked by coupled HCO 3 − secretion through pendrin. As ASL acidification has recently been demonstrated to increase mucus viscosity 11 , ASL acidification caused by excessive ATP12A mediated proton secretion would appear to be a compelling mechanistic explanation for the mucus dysfunction caused by T2 inflammation. However, our data suggest that the ATP12A effect on mucus rheology is pH independent.
Several pH independent mechanisms to explain how ATP12A increases ASL viscosity were considered. First, the coupled activity of ATP12A and pendrin likely result in net KCl absorption that osmotically drives water absorption and increases the relative mucin content of the ASL. The relatively high concentration of K + in the ASL (20-30 mM) compared to other extracellular fluids suggest that sufficient quantities of potassium ions are present to influence osmotically driven water transport 45 . The notion that KCl transport contributes to ASL regulation is supported by recent work indicating that K + secretion by BK channels is required for airway surface hydration [46] [47] [48] [49] . Moreover, significant decreases in the extracellular [K + ] is predicted to reduce the electrochemical gradient required for Cl − secretion though CFTR and other apical Cl − channels. Thus, the coupled activity of ATP12A and pendrin may promote relative ASL dehydration and thereby increase viscosity and impair mucus clearance. Alternatively, ATP12A activity may increase viscosity through direct mucin modification. The mucin Data shown is average τ ASL /τ saline ± SEM in primary HBE cells with and without lentiviral shRNA ATP12A knockdown ± IL-13, n = 12 replicates from three tissue donors, **p = 0.0003 via unpaired Student's t-test. (d) The increase in ASL viscosity is directly proportional to the level of ATP12A protein expression. Open circles represent ATP12A knockdown cultures and IL-13 treated cultures are shown in red. Data shown is mean τ ASL / τ saline ± SEM (vertical error bars) and mean relative ATP12A protein expression ± SEM (horizontal error bars). Data represents 9 replicates from 3 tissue donors (R 2 = 0.99, P = 0.0047). (e) ASL pH is not changed by lack of ATP12A expression. Data shown is mean ASL pH ± SEM, n = 9 replicates from 2 tissue donors, ***p = 0.0001 and ****p = 0.0014 by unpaired Student's t-test. biochemistry and structure may be impacted prior to or during secretion through alterations in the luminal composition or pH of secretory vesicles. Additionally, changes in relative cation concentrations may impact the rate of post-exocytotic swelling experienced by the freshly secreted mucin polymers 50, 51 . Airway mucins may also act as a proton buffer and therefore ATP12A driven proton secretion may promote mucus oxidation. Mucus oxidation increases inter-and intra-molecular disulfide bond formation and limits the ability of mucins to hold water 52 . Further studies are required to define the mechanism by which ATP12A increases mucus viscosity.
The airway diseases associated with T2 inflammation and CF are characterized by mucus dysfunction and impaired mucocilliary clearance. However, the pathophysiological mechanisms of these airway diseases appear to be mechanistically different. In CF, alterations in ion transport caused by dysfunctional CFTR render the airway surface vulnerable to a reduction in the ASL height and promote the development of excessively viscous mucus. The ASL height defect has been attributed to decreased Cl − secretion coupled with increased ENaC mediated Na + absorption. The concomitant mucus dysfunction in CF is believed to be due to increased acidity caused by impaired CFTR mediated HCO 3 − secretion. In contrast to the pathobiology of CF, T2 inflammatory cytokines have the opposite effects on ion transport; CFTR and TMEM16A activity are increased and ENaC activity is decreased. We did not appreciate a decrease in ASL height or pH in HBE cells exposed to IL-13 (Figs 4b and 5a ). The mucus dysfunction observed in response to T2 inflammation is associated with, and requires, increased ATP12A expression and activity. While ATP12A activity is not abnormal in CF HBE, its expression does appear to be required for the development of the mucus dysfunction and host defense impairments associated with CF airway disease 31, 33 . Perhaps the increased exacerbation frequency and increased rate of lung function decline that occurs in individuals with CF and concomitant allergic bronchopulmonary aspergillosis can be explained by additional mucus dysfunction caused by T2 inflammation 53 . Further studies are required to determine whether the mucus dysfunction associated with T2 inflammation is additive to the mucus clearance impairments associated with CF.
In summary, these data indicate that ATP12A is a novel regulator of ASL viscosity and suggest that mucus dysfunction seen in T2 inflammatory airway diseases would be mitigated by the inhibition of ATP12A. The increased mucus viscosity associated with IL-13 appears to be independent of ASL height and develops despite increased electrogenic Cl − secretion and Na + absorption. Interestingly, ATP12A appears to increase ASL viscosity by a pH independent mechanism that will require additional studies to define. Based on the profound effects on mucus transport, ATP12A is a compelling potential therapeutic target to improve mucus dysfunction in T2 airway diseases.
Materials and Methods
Primary human airway epithelial cell culture. Following attainment of informed consent, airway segments and lung tissue were obtained from excess pathological tissue following lung transplantation in accordance with a protocol approved by the University of Pittsburgh Investigational Review Board 54 . Epithelial cells were removed from the underlying musculature by blunt dissection, isolated by centrifugation, and re-suspended in BronchiaLife epithelial airway media (Lifeline Cell Technology, Frederick, MD). The cells were grown to 80-90% confluence in collagen-coated flasks and then seeded into collagen-coated 0.33 cm 2 Costar transwell filters (Corning Costar) at a density of ~5-6 × 10 5 cells/cm 2 . The cells were cultured at air-liquid interface and considered differentiated when a mucociliary phenotype was apparent on phase contrast microscopy (3-6 weeks). Differentiated HBE cells were cultured ± IL-13 (10 ng/mL added to the basolateral growth media) for 3-5 days prior to being studied. ASL meniscus volume measurement. Plates containing 12 culture filter insets were visualized on an optical scanner (Epson V500 optical scanner, Japan). Using an automated image analysis algorithm developed in Image J (NIH, Bethesda, MD), the changes in light intensity as it passes through the apical fluid meniscus were measured along radial spokes from the center to the edge of each transwell filter insert and fit to a sigmoidal function. The area under the curve was integrated to an experimentally determined volume calibration curve using a custom algorithm as previously described 34 . As this algorithm can lead to a negative values for volumes that were too small to be aspirated during the initial volume calibration, the results were analyzed such that the lowest average negative volume per tissue donor was set to zero and this was used as a correction factor for the remaining volume readings for that line.
Short-circuit current recordings. Differentiated HBE cultures were mounted in Ussing chambers (P2300;
Physiological Instruments, San Diego, CA) and cultures were continuously short-circuited with an automatic voltage clamp (VCC MC8, Physiological Instruments) as previously described 54 . Chambers were constantly gassed with a mixture of 95% O 2 /5% CO 2 at 37 °C, which maintained the pH at 7.4. The apical and basolateral chambers each contained 3 mL of Ringer's solution (120 mM NaCl, 25 mM NaHCO 3 , 3.3 mM KH 2 PO 4 , 0.8 mM K 2 HPO 4 , 1.2 mM MgCl 2 , 1.2 mM CaCl 2 , and 10 mM glucose). Simultaneous transepithelial resistance was recorded by applying a 10-mV pulse per second via an automated pulse generator. Acquire and Analyze 2.3 (Physiological Instruments) was used to control the voltage clamp and analyze I SC data.
ASL height and viscosity measurements.
The ASL of rinsed, differentiated, HBE cultures was labeled with 10 µL of 70 kDa FITC-labeled dextran (20 mg/mL, Sigma-Aldrich, St. Louis, MO). The following morning, 50 µL of perfluorocarbon (FC-770, ACROS organics, ThermoFisher, Waltham, MA) was applied to the apical surface to prevent evaporative losses during evaluation. The cultures were then placed on a modified stage of a Nikon TiE inverted microscope equipped with a Nikon confocal A1 scanner and the ASL was visualized with a 40× water immersion objective (Nikon Apo LWD 1.15 NA). To measure the ASL height, a random 320 µm × 20 µm × 30-50 µm region in the center of the culture was selected and imaged. The images of the ASL were analyzed using an automated method as previously described by Song et al. 38 .
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The ASL viscosity was measured using fluorescent recovery after photobleaching (FRAP) as previously described 41 . After obtaining a baseline image, a small region (6 × 18 µm) in the middle of the ASL was photobleached for 400 milliseconds. Following photobleaching serial images of the region were acquired. The data was fit to an exponential rise to max function to determine the time constant (τ) for fluorescence recovery. The FRAP data is expressed as the ratio of the τ of ASL recovery relative to that of saline (τ ASL / τ saline ). ASL pH measurement. ASL pH was measured using the pH-sensitive ratiometric fluorophore 2′,7′-bis -(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) conjugated to 10 kDa dextran (Sigma-Aldrich). 1 mg/ mL BCECF dextran was applied to the apical surface. The HCO 3 − containing solution consisted of 120 mM NaCl, 5 mM KCl, 1.2 mM CaCl 2 , 1.2 mM MgCl 2 , 25 mM NaHCO 3 , 5 mM HEPES, and 10 mM glucose and pH measurements were conducted in 5% CO 2 . The HCO 3 − free solution consisted of 125 mM NaCl, 5 mM KCl, 1.2 mM CaCl 2 , 1.2 mM MgCl 2 , 5 mM sodium gluconate, 20 mM HEPES, and 10 mm glucose and the measurements were performed in room air.
The individual cell filter inserts were mounted on a modified stage of a Nikon TiE inverted microscope that maintained the temperature at 37 °C. The ASL was then visualized with a 20× objective (Nikon CFI Apochromat λ 0.75 NA). Ratiometric measurement of the BCECF was performed at 490 nm/440 nm excitation and 535 nm emission wavelengths using a metal arc illuminator and appropriate BCECF filters (Chroma, Bellows Falls, VT). A calibration curve of the BCECF 490 nm/440 nm ratio to ASL pH was generated as previously described 42 . Four predetermined regions on each culture insert were imaged, background corrected, and averaged. Steady state ASL pH was measured after 4 h of equilibration. The rate of ASL pH change was measured over a 10 min period after the addition of the BCECF-study solution.
Measurements of ciliary function. The fraction of functional ciliated airway (FFCA) measurement was performed as previously described 35 . Briefly, differentiated HBE cell cultures were visualized by phase microscopy on a Nikon TiE inverted microscope. A series of 10 sequential images of the apical surface was obtained and the change in light intensity over time for each pixel was calculated. The area containing motile cilia was derived from the change in pixel intensity above background using a custom algorithm in ImageJ. These measurements were repeated before and after apical rinsing with 10 µL Ringer's solution.
Ciliary beat frequency (CBF) measurements were performed on differentiated HBE cell cultures. High frame rate videos of the ciliary motion were obtained using a Nikon TiE inverted microscope equipped with an EXi Blue camera (Qimaging, Surrey, Canada). The variation in pixel frequency was fit to a fast Fourier transform (FFT) using a custom algorithm in ImageJ and the mean ciliary beat frequency observed across the field is reported 36 .
Mucociliary transport (MCT) measurement were performed as previously described 5 . Briefly, 1 μm fluorescent microspheres (Invitrogen) were applied to the apical mucus of primary HBE cell cultures. Cultures were visualized on a modified stage of a Nikon TiE inverted microscope and a 5 s exposure was captured. The lengths of the streak created by >5 microspheres per culture were measured.
Western blotting. HBE cell cultures were rinsed and then lysed by manual scrapping in 100 µL of lysis buffer (10 mM Tris-Cl, 50 mM EGTA, 0.4% sodium deoxycholate, 1% Nonidet P-40, pH 7.4). The resultant proteins were separated by SDS-PAGE on 4-12% gels (Novex Tris/glycine, Invitrogen/ThemoFisher Scientific, Carlsbad, CA) and transferred to nitrocellulose membranes. The membranes were cut between the 50 and 75 kd markers. The membranes from the top half were blocked with 5% nonfat dry milk, blotted with a previously characterized rabbit anti-ATP12A antibody (1:5000, Novus biologicals, Litteton, CO) 33 , and visualized with 1:5000 HRP conjugated anti-rabbit secondary antibodies (BioRad, Hercules, CA). The membranes from the bottom half were blocked with 5% nonfat dry milk, blotted with a monocolonal β actin antibody (Sigma-Aldrich) and visualized with species appropriate HRP conjugated secondary antibodies. Band intensity was quantitated by densitometry using Image J and normalized to level of β-actin expression per individual tissue donor. rtPCR. To measure ATP12A mRNA levels, HBE cell cultures were rinsed and then lysed by manual scraping with 200 µL Trizol reagent (Invitrogen) followed by column purification (Zymo, Irvine, CA). The RNA was then converted to cDNA via the High Capacity cDNA RT kiT (Invitrogen). Absolute quantification with real time PCR was performed utilizing the TaqMan method (ATP12A TaqMan gene expression assay Hs01060284_m1, Life Technologies, Carlsbad, CA) with the Lightcycler 96 System (Roche, Switzerland).
ATP12A knockdown. For ATP12A siRNA knockdown, ATP12A DsiRNA (Integrated DNA Technologies, San Diego, CA) was delivered to primary HBE using reverse transfection as previously described 55 .
Lentiviral vectors containing shRNA directed towards ATP12A (Clone TRCN0000043153, TRC ATP12A shRNA set, GE Dharmacon, Lafayette, CO) were expressed in HEK293 along with the 3 rd generation lentiviral packaging constructs pMDLg/pRRE, pRSV-Rev, and pMD2.G (Plasmid #12251, #12253, and #12259 respectively, Addgene, Cambridge, MA). Plasmids were gifts from Didier Trono 56 . Lentiviral particles were created using the ProFection Mammalian Transfection System (Promega, Madison, WI). Undifferentiated HBE cells were transduced with ATP12A shRNA or empty lentiviral vectors when seeded onto transwell inserts as previously described 47, 57 . Two to three days later, the selection antibiotic puromycin (1 µg/mL) was added to the basolateral media. The cultures were cultured for 3-4 weeks before experimentation to allow for differentiation.
Statistical analyses.
All data is expressed as mean ± SEM unless otherwise noted. Significance was determined by two-tailed paired or unpaired Student's t-test as noted. Normalized, nonparametric data was analyzed using the Mann-Whitney rank sum test. P < 0.05 was considered statistically significant.
